Metabolism 2014 – Alterations of metabolic pathways as therapeutic targets
Glycogen metabolism in cancer
Heterogeneity of glycolysis in cancers and therapeutic opportunities
Modulatory roles of glycolytic enzymes in cell death
Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity
Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: A therapeutic implication
MCL-1 dependency of cisplatin-resistant cancer cells
Mitochondrial dysfunction in cancer chemoresistance
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
Targeting antioxidants for cancer therapy
Energy restriction mimetic agents to target cancer cells: Comparison between 2-deoxyglucose and thiazolidinediones
Pharmacological potential of bioactive engineered nanomaterials
Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes
Docosahexaenoic acid inhibits insulin-induced activation of sterol regulatory-element binding protein 1 and cyclooxygenase-2 expression through upregulation of SIRT1 in human colon epithelial cells
P53 and Sirt1: Routes of metabolism and genome stability
Poly(ADP-ribose): A signaling molecule in different paradigms of cell death
PARP and other prospective targets for poisoning cancer cell metabolism